Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine two nitric oxide donors, on hormonal secretions and blood pressure in man

Journal of Endocrinological Investigation

Volumn 20, Issue 8, 1997, Pages 488-492

  Maccario, M ^a   Oleandri, S E ^a   Procopio, M ^a   Grottoli, S ^a   Avogadri, E ^a   Camanni, F ^a   Ghigo, E ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Arginine; Blood pressure; GH; Glucose; Insulin; Isosorbide dinitrate; Moisidomine; PRL

Indexed keywords

ARGININE; GLUCOSE; GROWTH HORMONE; INSULIN; ISOSORBIDE DINITRATE; MOLSIDOMINE; NITRIC OXIDE; PROLACTIN; VASODILATOR AGENT;

ADULT; ARTICLE; ASTHENIA; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HEADACHE; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PROLACTIN RELEASE; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

EID: 0030731650     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348006     Document Type: Article

References (32)

1. Parker M.L., Hammond J.M., Daughaday W.H. The arginine provocative test: an aid in the diagnosis of hyposomatotropism. J. Clin. Endocrinol. Metab. 27: 1129, 1967.
2. Floyd J.C., Fajams S.S., Knopf R.F., Rull J., Conn J.W. Stimulation of insulin secretion by aminoacids. Clin. Res. 13: 323, 1965.
3. Racoff J.S., Siler T.M., Sinha Y.N., Yen S.S.C. Prolactin and Growth hormone release in response to sequential stimulation by arginine and synthetic TRF. J. Clin. Endocrinol. Metab. 37: 641, 1973.
4. Petras A.J., Hewlet A.M., Bogle R.G., Pearson J.D. L-arginine-induced hypothension. Lancet 337: 1044, 1991.
5. Hishikawa K., Nakaki T., Tsuda M., Esumi H., Oshima H., Suzuki H., SarutaT., Kato R. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn. Heart J. 33: 41, 1992.
6. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilatation. J. Clin. Endocrinol. Metab. 78: 1, 1986.
7. Moncada S., Radonski M.W., Palmer R.N. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of the vascular tone and platelet function. Biochem. Pharmacol. 37: 2495, 1988.
8. Schmidt H.H.H.W., Warner T.D., Ishii K., Sheng H., Murad F. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science 721, 1992.
9. Rudolph W., Dirschinger J. Clinical comparison of nitrates and sydnomines. Eur. Heart J., Nov. 12 suppl EP, 33, 1991.
10. Feelish M., Ostrowsky J., Noack E. On the mechanism of NO release from sydnonimimes. J. Cardiovasc. Pharmacol., 14, suppl 11PS 13, 1989.
11. Alba Roth J., Muller O.A., Schopohl J., von Wevder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.
12. Kopperschaar H.P.F., ten Horn C.D., Thijssen J.H.H., Page M.D., Dieguez C., Scanlon M.F. Differential effects of arginine on growth hormone releasing hormone and insulin induced growth hormone secretion. Clin. Endocrinol. (Oxf.) 36: 487, 1992.
13. Ghigo E., Bellone J., Mazza E., Imperiale E., Procopio M., Valente F., Lala R., De Sanctis C., Camanni F. Arginine potentiates the GHRH-induced GH secretion in normal short children, further evidence for a somatostatin suppressing effect of arginine. Clin. Endocrinol. (Oxf.) 32: 342, 1990.
14. Barbul A. Arginine: biochemistry, Physiology and therapeutic implications. Parent. Enter. Nutrition 10: 227, 1986.
15. Utsumi M., Makimura H., Ishihara K. Determination of immunoreactive somatostatin in rat plasma and responses to arginine, glucose and glucagon infusion. Diabetologia 17: 319, 1979.
16. Van Haeften T.W., Voetberg G.A., Gerich J.E., Van deer Veen E.A. Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycaemia. J. Clin. Endocrinol. Metab 69: 1059, 1989.
17. Blachier F., Mourtada A., Sener A., Malaisse J. Stimulus-secretion coupling of arginine-induced insulin release. Uptake of metabolised and non metabolised cationic aminoacid by pancreatic islets. Endocrinology 124: 134, 1988.
18. Janson L., Sandier S. The nitric oxide synthase II inhibitor NG -nitro-L-arginine stimulates pancreatic islet insulin release in vitro, but not in the perfused pancreas. Endocrinology 128: 3081, 1991.
19. Sener A., Blachier F., Rasschaert J., Malaisse W.J. Stimulus-secretion coupling of arginine-induced insulin release: comparison with histidine-induced insulin release. Endocrinology 127: 107, 1990.
20. Vallance P., Collier J., Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiov. Res. 23: 1053, 1989.
21. Bredt D.S., Hwang P.M., Synder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768, 1990.
22. Bredt D.S., Synder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87: 682, 1990.
23. Pedrinelli R., Ebel M., Catapano G., Dell'Omo G., Ducci M., Del Chicca M., Clerico A. Pressor, renal and endocrine effects of L-arginine in essential hypertensives Eur. J. Clin. Pharmacol. 48: 195, 1995.
24. Kato M. Involvement of nitric oxide in growth hormone (GH)-releasing hormone-induced GH secretion in rat pituitary cells. Endocrinology 131: 2133, 1992.
25. Costa A., Trainer P., Besser G.M., Grossman A.B. Nitric oxide modulates the release of the corticotrophin-releasing hormone from the rat hypothalamus in vitro. Brain Res. 605: 187, 1993.
26. Rettori V., Belova N., Gimeno N., Mc Cann S.M. Inhibition of nitric oxide synthase in the hypothalamus blocks the increase in plasma prolactin induced by intraventricular injection of interleukin-1 α in the rat. Neuroimmunomodulation 1: 116, 1994.
27. Moretto M., Lopez J.J., Negro-Vilar A. Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology 133: 2399, 1993.
28. Laffranchi R., Gogvadze V., Richter C., Spinas G.A. Nitric Oxide (nitrogen monoxide, NO) stimulates insulin secretion by inducing calcium release from mitochondria B.B.R.C 217: 2, 584, 1995.
29. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997, 1989.
30. Calver A., Collier J., Vallance P. L-arginine-induced hypotension. Lancet 336: 1016, 1990.
31. Korbut R., Bieron K., Gryglewski R.J. Effect of L-arginine on plasminogen-activator inhibitor in hypertensive patient with hypercholesterolemia. N. Engl. J. Med. 328: 287, 1993.
32. MacAllister R.J., Calver A.L., Collier J., Edwards C.M.B., Herreros B., Nussey S.S., Vallance P. Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? Clin. Sci. 89: 183, 1995.